Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Toxic Reactions: Overview

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

Drug Toxicity: Overview

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.

Cancer control : journal of the Moffitt Cancer Center·2015

Same author

Pharmacological Management of Cancer-Related Pain.

Cancer control : journal of the Moffitt Cancer Center·2015

Same author

Palliative Oncologists: Specialists in the Science and Art of Patient Care.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2015

Same author

Fentanyl (transmucosal).

Journal of pain and symptom management·2012

Same author

Ketamine for pain: an update of uses in palliative care.

Journal of palliative medicine·2012

Same author

Octreotide.

Journal of pain and symptom management·2011

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

Toxicity of bisphosphonates.

Eric E Prommer¹

¹Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona 85259, USA. prommer.eric@mayo.edu

Journal of Palliative Medicine

|November 20, 2009

Summary

This summary is machine-generated.

Bisphosphonates effectively palliate metastatic bone disease but can cause significant toxicities in advanced cancer patients. This case highlights these risks and offers management guidelines for bisphosphonate-associated toxicities.

Related Experiment Videos

Last Updated: Jun 18, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

Area of Science:

Oncology
Pharmacology
Bone Metastasis Management

Background:

Bisphosphonates are crucial for managing metastatic bone disease in cancer patients.
The widespread application of bisphosphonates necessitates a thorough understanding of their potential toxicities.
Patient morbidity associated with bisphosphonate use requires careful consideration.

Observation:

This case presentation details specific toxicities observed during bisphosphonate therapy.
The focus is on adverse events that impact patients with advanced cancer.

Findings:

Bisphosphonates, while beneficial, are associated with significant toxicities.
Recognition and understanding of these toxicities are essential for patient care.

Implications:

Guidelines for the safe and effective use of bisphosphonates are needed.
Proactive management strategies for bisphosphonate-induced toxicities can improve patient outcomes.
This case underscores the importance of balancing therapeutic benefits with risk management in cancer treatment.